348 related articles for article (PubMed ID: 5566729)
1. Pharmacology of narcotics and antagonists as related to drug abuse.
Elliott HW
Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):459-61. PubMed ID: 5566729
[No Abstract] [Full Text] [Related]
2. Induction of physical dependence on morphine, codeine and meperidine in the rat by continuous infusion.
Teiger DG
J Pharmacol Exp Ther; 1974 Sep; 190(3):408-15. PubMed ID: 4472146
[No Abstract] [Full Text] [Related]
3. The analgesic effect of opiate-opiate antagonist combinations in the rat.
Grumbach L; Chernov HI
J Pharmacol Exp Ther; 1965 Sep; 149(3):385-96. PubMed ID: 5848049
[No Abstract] [Full Text] [Related]
4. Studies on morphine. IX. On the intensity of the abstinence syndrome to morphine induced by daily injections of nalorphine in white mice.
Huidobro F; Maggiolo C
Arch Int Pharmacodyn Ther; 1965 Nov; 158(1):97-112. PubMed ID: 5892561
[No Abstract] [Full Text] [Related]
5. Self administration: positive and negative reinforcing properties of morphine antagonists in rhesus monkeys.
Hoffmeister F; Wuttke W
Adv Biochem Psychopharmacol; 1973; 8(0):361-9. PubMed ID: 4212335
[No Abstract] [Full Text] [Related]
6. Effects of narcotic analgesics and antagonists on the in vivo release of acetylcholine from the cerebral cortex of the cat.
Jhamandas K; Phillis JW; Pinsky C
Br J Pharmacol; 1971 Sep; 43(1):53-66. PubMed ID: 5136464
[TBL] [Abstract][Full Text] [Related]
7. Subjective effects of narcotic antagonists.
Haertzen CA
Adv Biochem Psychopharmacol; 1973; 8(0):383-98. PubMed ID: 4795096
[No Abstract] [Full Text] [Related]
8. Drug action on tail shock-induced vocalization in mice and its relevance to analgesia.
Weller CP; Sulman FG
Eur J Pharmacol; 1970 Feb; 9(2):227-34. PubMed ID: 5437157
[No Abstract] [Full Text] [Related]
9. Modification of the analgesic action of pethidine and morphine by three opiate antagonists, a respiratory stimulant (doxapram) and an analeptic (nikethamide); a study using an experimental pain stimulus in man.
Dundee JW; Gupta PK; Jones CJ
Br J Pharmacol; 1973 Jun; 48(2):326P. PubMed ID: 4733735
[No Abstract] [Full Text] [Related]
10. Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists.
Fraser HF
Adv Biochem Psychopharmacol; 1973; 8(0):439-53. PubMed ID: 4604198
[No Abstract] [Full Text] [Related]
11. Opiate antagonists and 'blockers'.
Murphree HB
Am Fam Physician; 1973 Apr; 7(4):136-7. PubMed ID: 4694336
[No Abstract] [Full Text] [Related]
12. Agonistic properties of narcotic analgesics and antagonists on the electroencephalogram and behavior in the rat and their reversal by naloxone.
Colasanti B; Khazan N
Neuropharmacology; 1973 Jul; 12(7):619-27. PubMed ID: 4730371
[No Abstract] [Full Text] [Related]
13. The effects of narcotic analgesics and narcotic antagonists on ganglionic transmission in the rat.
Forbes JE; Dewey WL
Life Sci; 1976 Aug; 19(3):401-7. PubMed ID: 183075
[No Abstract] [Full Text] [Related]
14. Clinical pharmacology of the narcotic analgesics.
VANDAM LD
Clin Pharmacol Ther; 1962; 3():827-38. PubMed ID: 13996168
[No Abstract] [Full Text] [Related]
15. A quantitative method for the assessment of physical dependence on narcotic analgesics in mice.
Marshall I; Weinstock M
Br J Pharmacol; 1969 Oct; 37(2):505P-506P. PubMed ID: 5388579
[No Abstract] [Full Text] [Related]
16. DRUG ADDICTION: A REVIEW.
MEYERSTEIN AN
J Sch Health; 1964 Feb; 34():77-87. PubMed ID: 14125210
[No Abstract] [Full Text] [Related]
17. The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone).
Jasinski DR; Martin WR; Haertzen CA
J Pharmacol Exp Ther; 1967 Aug; 157(2):420-6. PubMed ID: 6039832
[No Abstract] [Full Text] [Related]
18. [Suspension of the tonus-increasing effect of morphine and pethidine on the extrahepatic bile ducts by specific morphine antagonists].
Bräunlich H
Z Arztl Fortbild (Jena); 1965 Dec; 59(23):1276-9. PubMed ID: 5888483
[No Abstract] [Full Text] [Related]
19. Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).
Kosterlitz HW; Watt AJ
Br J Pharmacol Chemother; 1968 Jun; 33(2):266-76. PubMed ID: 5664147
[No Abstract] [Full Text] [Related]
20. Antagonists in the 5-phenyl-benzomorphan series.
Clarke FH; Hill RT; Saelens JK; Yokoyama N
Adv Biochem Psychopharmacol; 1973; 8(0):81-9. PubMed ID: 4211809
[No Abstract] [Full Text] [Related]
[Next] [New Search]
